In the cytotoxicity evaluation, it was proven that CD1:ASO, CD2:ASO, and CD3:ASO nanocomplexes were not toxic to striatal neuronal cells nor HD patient-derived fibroblasts under the conditions used. Here, CD2 is linked to Huntington disease.